206 related articles for article (PubMed ID: 25380122)
1. Challenges in ototoxicity monitoring in the pediatric oncology population.
Bass JK; Bhagat SP
J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
[TBL] [Abstract][Full Text] [Related]
2. Audiological monitoring in Swiss childhood cancer patients.
Weiss A; Kuonen R; Brockmeier H; Grotzer M; Candreia C; Maire R; Senn P; Stieger C; Rosenfeld J; Veraguth D; Kompis M; Scheinemann K; Kuehni CE;
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29230928
[TBL] [Abstract][Full Text] [Related]
3. Is Methotrexate Ototoxic? Investigating the Ototoxic Late Effects of Pediatric Cancer Treatment.
Moore B; Sheets G; Doss J; Umrigar A; Norman M; Fang Z; Prasad P; Musso A; Clay S; Tsien F
Am J Audiol; 2023 Sep; 32(3):657-664. PubMed ID: 37532243
[TBL] [Abstract][Full Text] [Related]
4. Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy.
Cohen-Cutler S; Wong K; Mena V; Sianto K; Wright MA; Olch A; Orgel E
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1488-1495. PubMed ID: 33677052
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report.
Meijer AJM; van den Heuvel-Eibrink MM; Brooks B; Am Zehnhoff-Dinnesen AG; Knight KR; Freyer DR; Chang KW; Hero B; Papadakis V; Frazier AL; Blattmann C; Windsor R; Morland B; Bouffet E; Rutkowski S; Tytgat GAM; Geller JI; Hunter LL; Sung L; Calaminus G; Carleton BC; Helleman HW; Foster JH; Kruger M; Cohn RJ; Landier W; van Grotel M; Brock PR; Hoetink AE; Rajput KM;
JAMA Oncol; 2021 Oct; 7(10):1550-1558. PubMed ID: 34383016
[TBL] [Abstract][Full Text] [Related]
6. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
Fetoni AR; Brigato F; De Corso E; Lucidi D; Sergi B; Scarano E; Galli J; Ruggiero A
Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4677-4686. PubMed ID: 35024956
[TBL] [Abstract][Full Text] [Related]
7. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
Bass JK; Huang J; Onar-Thomas A; Chang KW; Bhagat SP; Chintagumpala M; Bartels U; Gururangan S; Hassall T; Heath JA; McCowage G; Cohn RJ; Fisher MJ; Robinson G; Broniscer A; Gajjar A; Gurney JG
Pediatr Blood Cancer; 2014 Apr; 61(4):601-5. PubMed ID: 24504791
[TBL] [Abstract][Full Text] [Related]
8. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
Knight KR; Kraemer DF; Neuwelt EA
J Clin Oncol; 2005 Dec; 23(34):8588-96. PubMed ID: 16314621
[TBL] [Abstract][Full Text] [Related]
9. Ototoxicity and cancer therapy.
Landier W
Cancer; 2016 Jun; 122(11):1647-58. PubMed ID: 26859792
[TBL] [Abstract][Full Text] [Related]
10. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
11. Applications of the Grading Scales for the Detection of Ototoxicity in Children after Treatment of Neuroblastoma and Extracranial Germinal Tumor.
Polski B; Sosnowska-Sienkiewicz P; Szydłowski J; Januszkiewicz-Lewandowska D
Audiol Neurootol; 2023; 28(1):32-42. PubMed ID: 36191558
[TBL] [Abstract][Full Text] [Related]
12. Hearing loss related to ototoxicity in children with cancer.
Landier W
J Pediatr Oncol Nurs; 1998 Oct; 15(4):195-206. PubMed ID: 9810786
[TBL] [Abstract][Full Text] [Related]
13. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.
Brock PR; Knight KR; Freyer DR; Campbell KC; Steyger PS; Blakley BW; Rassekh SR; Chang KW; Fligor BJ; Rajput K; Sullivan M; Neuwelt EA
J Clin Oncol; 2012 Jul; 30(19):2408-17. PubMed ID: 22547603
[TBL] [Abstract][Full Text] [Related]
14. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.
Paken J; Govender CD; Sewram V
BMC Womens Health; 2017 Dec; 17(1):129. PubMed ID: 29228931
[TBL] [Abstract][Full Text] [Related]
15. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.
Garinis AC; Cornell A; Allada G; Fennelly KP; Maggiore RJ; Konrad-Martin D
Int J Audiol; 2018 Sep; 57(sup4):S19-S24. PubMed ID: 28978238
[TBL] [Abstract][Full Text] [Related]
16. Ototoxicity monitoring in children treated with platinum chemotherapy.
Brooks B; Knight K
Int J Audiol; 2018 Sep; 57(sup4):S34-S40. PubMed ID: 28737048
[TBL] [Abstract][Full Text] [Related]
17. Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center.
Gambacorta V; Orzan E; Faralli M; Gullà M; Lapenna R; Baietta I; De Angelis V; Ricci G
Audiol Res; 2023 Oct; 13(5):779-790. PubMed ID: 37887850
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
Clemens E; van den Heuvel-Eibrink MM; Mulder RL; Kremer LCM; Hudson MM; Skinner R; Constine LS; Bass JK; Kuehni CE; Langer T; van Dalen EC; Bardi E; Bonne NX; Brock PR; Brooks B; Carleton B; Caron E; Chang KW; Johnston K; Knight K; Nathan PC; Orgel E; Prasad PK; Rottenberg J; Scheinemann K; de Vries ACH; Walwyn T; Weiss A; Am Zehnhoff-Dinnesen A; Cohn RJ; Landier W;
Lancet Oncol; 2019 Jan; 20(1):e29-e41. PubMed ID: 30614474
[TBL] [Abstract][Full Text] [Related]
19. Audiologists' perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey.
Konrad-Martin D; Polaski R; DeBacker JR; Theodoroff SM; Garinis A; Lacey C; Johansson K; Mannino R; Milnes T; Hungerford M; Clark KD
J Cancer Surviv; 2023 Feb; 17(1):69-81. PubMed ID: 36729345
[TBL] [Abstract][Full Text] [Related]
20. The experience of hearing loss in adult survivors of childhood and young adult cancer: A qualitative study.
Khan A; Mubdi N; Budnick A; Feldman DR; Williams SW; Patel S; Tonorezos ES
Cancer; 2020 Apr; 126(8):1776-1783. PubMed ID: 31899553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
